Casodex vs Placebo in Non-Metastatic Early Prostate Cancer (Q64047459)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Casodex vs Placebo in Non-Metastatic Early Prostate Cancer
clinical trial

    Statements

    SPCG6 (English)
    0 references
    A Randomized, Double-Blind, Parallel-Group Trial Comparing Casodex 150mg Once Daily With Placebo in Patients With Non-Metastatic Prostate Cancer. (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    October 1995
    0 references
    1,218
    0 references
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit